Results 141 to 150 of about 17,862 (264)

Impact of TOPAZ-1 eligibility on the survival benefit of durvalumab plus gemcitabine-cisplatin in advanced biliary tract cancer: a multicenter real-world study. [PDF]

open access: yesJ Gastroenterol
Kosaka H   +25 more
europepmc   +1 more source

Durvalumab Plus Chemotherapy for Advanced Biliary Tract Cancer: A Post Hoc Analysis of the TOPAZ-1 Randomized Clinical Trial.

open access: yesJAMA Oncol
Oh DY   +9 more
europepmc   +1 more source

Real-world survival benefit of adding durvalumab to chemotherapy in cholangiocarcinoma: a retrospective cohort analysis from a German Comprehensive Cancer Centre. [PDF]

open access: yesESMO Real World Data Digit Oncol
Elbasan S   +17 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy